{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:17:49Z","timestamp":1784625469680,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,10,1]]},"DOI":"10.1038\/sj.bmt.1703224","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:39:08Z","timestamp":1032280748000},"page":"753-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients"],"prefix":"10.1038","volume":"28","author":[{"given":"P","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RC","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,11,22]]},"reference":[{"key":"BF1703224_CR1","first-page":"1374","volume":"27","author":"JW Fay","year":"1995","unstructured":"Fay JW, Nash RA, Wingard JR et al. FK 506-based immunosuppression for prevention of graft-versus-host disease after unrelated donor marrow transplantation Transplant Proc 1995 27: 1374","journal-title":"Transplant Proc"},{"key":"BF1703224_CR2","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514","volume":"87","author":"JW Fay","year":"1996","unstructured":"Fay JW, Wingard JR, Antin JH et al. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation Blood 1996 87: 3514\u20133519","journal-title":"Blood"},{"key":"BF1703224_CR3","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746","volume":"85","author":"RA Nash","year":"1995","unstructured":"Nash RA, Etzioni R, Storb R et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study Blood 1995 85: 3746\u20133753","journal-title":"Blood"},{"key":"BF1703224_CR4","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood.V88.9.3634.bloodjournal8893634","volume":"88","author":"RA Nash","year":"1996","unstructured":"Nash RA, Pineiro LA, Storb R et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors Blood 1996 88: 3634\u20133641","journal-title":"Blood"},{"key":"BF1703224_CR5","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","volume":"88","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation Blood 1996 88: 4383\u20134389","journal-title":"Blood"},{"key":"BF1703224_CR6","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation Blood 1998 92: 2303\u20132314","journal-title":"Blood"},{"key":"BF1703224_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.bmt.1700813","volume":"19","author":"JP Uberti","year":"1997","unstructured":"Uberti JP, Silver SM, Adams PT et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies Bone Marrow Transplant 1997 19: 1233\u20131238","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR8","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors Blood 2000 96: 2062\u20132068","journal-title":"Blood"},{"key":"BF1703224_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","volume":"59","author":"GL Plosker","year":"2000","unstructured":"Plosker GL, Foster RH . Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation Drugs 2000 59: 323\u2013389","journal-title":"Drugs"},{"key":"BF1703224_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","volume":"29","author":"R Venkataramanan","year":"1995","unstructured":"Venkataramanan R, Swaminathan A, Prasad T et al. Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 1995 29: 404\u2013430","journal-title":"Clin Pharmacokinet"},{"key":"BF1703224_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bmt.1701054","volume":"21","author":"GW Boswell","year":"1998","unstructured":"Boswell GW, Bekersky I, Fay J et al. Tacrolimus pharmacokinetics in BMT patients Bone Marrow Transplant 1998 21: 23\u201328","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.bmt.1702053","volume":"24","author":"P Mehta","year":"1999","unstructured":"Mehta P, Beltz S, Kedar A et al. Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation Bone Marrow Transplant 1999 24: 1323\u20131327","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/sj.bmt.1701027","volume":"20","author":"M Woo","year":"1997","unstructured":"Woo M, Przepiorka D, Ippoliti C et al. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation Bone Marrow Transplant 1997 20: 1095\u20131098","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1083-8791(98)50005-5","volume":"4","author":"JR Wingard","year":"1998","unstructured":"Wingard JR, Nash RA, Przepiorka D et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation Biol Blood Marrow Transplant 1998 4: 157\u2013163","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703224_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bmt.1702032","volume":"24","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Devine S, Fay J et al. Practical considerations in the use of tacrolimus for allogeneic marrow transplantation Bone Marrow Transplant 1999 24: 1053\u20131056","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR16","first-page":"25","volume":"3","author":"SM Devine","year":"1997","unstructured":"Devine SM, Geller RB, Lin LB et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis Biol Blood Marrow Transplant 1997 3: 25\u201333","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703224_CR17","first-page":"895","volume":"15","author":"MT Koehler","year":"1995","unstructured":"Koehler MT, Howrie D, Mirro J et al. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 1995 15: 895\u2013899","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome New Engl J Med 1996 334: 494\u2013500","journal-title":"New Engl J Med"},{"key":"BF1703224_CR19","first-page":"569","volume":"18","author":"SM Devine","year":"1996","unstructured":"Devine SM, Newman NJ, Siegel JL et al. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation Bone Marrow Transplant 1996 18: 569\u2013572","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0025-6196(11)63771-3","volume":"71","author":"BF Boeve","year":"1996","unstructured":"Boeve BF, Kimmel DW, Aronson AE, de Groen PC . Dysarthria and apraxia of speech associated with FK-506 (tacrolimus) Mayo Clin Proc 1996 71: 969\u2013972","journal-title":"Mayo Clin Proc"},{"key":"BF1703224_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/sj.bmt.1701732","volume":"23","author":"RE Steg","year":"1999","unstructured":"Steg RE, Kessinger A, Wszolek ZK . Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation Bone Marrow Transplant 1999 23: 959\u2013962","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR22","first-page":"2748","volume":"23","author":"FC Grenier","year":"1991","unstructured":"Grenier FC, Luczkiw J, Bergmann M et al. A whole blood FK 506 assay for the IMx analyzer Transplant Proc 1991 23: 2748\u20132749","journal-title":"Transplant Proc"},{"key":"BF1703224_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJM197504242921706","volume":"292","author":"ED Thomas","year":"1975","unstructured":"Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts) New Engl J Med 1975 292: 895\u2013902","journal-title":"New Engl J Med"},{"key":"BF1703224_CR24","volume-title":"NONMEM User Guide","author":"L Beal","year":"1992","unstructured":"Beal L, Sheiner L . NONMEM User Guide San Francisco, CA, NONMEM Project Group, UCSF 1992"},{"key":"BF1703224_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/sj.bmt.1702588","volume":"26","author":"D Przepiorka","year":"2000","unstructured":"Przepiorka D, Blamble D, Hilsenbeck S et al. Tacrolimus clearance is age-dependent within the pediatric population Bone Marrow Transplant 2000 26: 601\u2013605","journal-title":"Bone Marrow Transplant"},{"key":"BF1703224_CR26","first-page":"1315","volume":"23","author":"A Lampen","year":"1995","unstructured":"Lampen A, Christians U, Guengerich FP et al. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability Drug Metab Dispos 1995 23: 1315\u20131324","journal-title":"Drug Metab Dispos"},{"key":"BF1703224_CR27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/00007890-199810270-00020","volume":"66","author":"Y Nakazawa","year":"1998","unstructured":"Nakazawa Y, Chisuwa H, Ikegami T et al. Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation Transplantation 1998 66: 1089\u20131093","journal-title":"Transplantation"},{"key":"BF1703224_CR28","first-page":"753","volume":"20","author":"M Sattler","year":"1992","unstructured":"Sattler M, Guengerich FP, Yun CH et al. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat Drug Metab Dispos 1992 20: 753\u2013761","journal-title":"Drug Metab Dispos"},{"key":"BF1703224_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/0003-9861(92)90711-5","volume":"294","author":"SH Vincent","year":"1992","unstructured":"Vincent SH, Karanam BV, Painter SK, Chiu SH . In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism Arch Biochem Biophys 1992 294: 454\u2013460","journal-title":"Arch Biochem Biophys"},{"key":"BF1703224_CR30","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0041-1345(98)00239-5","volume":"30","author":"S Sato","year":"1998","unstructured":"Sato S, Fuchinoue S, Tojimbara T et al. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients Transplant Proc 1998 30: 1274\u20131275","journal-title":"Transplant Proc"},{"key":"BF1703224_CR31","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0041-1345(98)00313-3","volume":"30","author":"WT Liu","year":"1998","unstructured":"Liu WT, Ren Y, Wang J, Wong PY . In vitro generation of tacrolimus metabolites and their detection in whole blood Transplant Proc 1998 30: 1454\u20131456","journal-title":"Transplant Proc"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703224","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:06:19Z","timestamp":1648073179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,10,1]]}},"alternative-id":["BF1703224"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703224","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,1]]},"assertion":[{"value":"15 February 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}